Abstract 1654: Pre-clinical activity of the Wnt/Beta-catenin pathway inhibitor RXC004 in models of biliary tract cancerSimon A. Woodcock, Caroline Phillips, Catherine Eagle et al.|Cancer Research|2023Cited by 0